ARYx Therapeutics, Inc. (ARYX)의 가격은 얼마입니까?

ARYx Therapeutics, Inc. (ARYX)의 가격은 $0.0005입니다.

ARYx Therapeutics, Inc. (ARYX)의 시가 총액은 무엇입니까?

ARYx Therapeutics, Inc. (ARYX)의 시가 총액은 $16.73K입니다.

ARYx Therapeutics, Inc. (ARYX) 주당순이익

Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.

연도	EPS	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

EPS

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	EPS	EPS 차이	국가
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-	IN

회사

EPS

EPS 차이

국가